FADD and neoplasm: Our GSEA suggests that tumor cell cycle pathways are enriched and cell proliferation is active in high FADD, and the active cell cycle provides more targets for conventional chemotherapeutic agents, thus leading to greater sensitivity to chemotherapy (39).